Phase III randomized, double-blind, placebo-controlled trial of soy protein and venlafaxine for treatment of hot flashes in men with prostate cancer.


9027 Background: Hot flashes (HFs) occur in approximately 2/3 of androgen-deprived men. There is limited data on treatment from prospective intervention studies. METHODS Eligible androgen-deprived men were randomly assigned to 1 of 4 daily regimens (2x2 factorial design) for 12 weeks: placebo pill and casein protein (P), soy protein and placebo pill (S… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.